COGNITION THERAPEUTICS INC
CGTXNext catalyst
CT1812
Early Alzheimer's Disease
Get an email about CGTX's next catalysts
Track COGNITION THERAPEUTICS (CGTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 1 past
CT1812 Phase 2 Est. Readout
Primary completion for CT1812 trial (NCT05531656) in Early Alzheimer's Disease
SourceHow CGTX's past catalysts played out
Market Overview
Stock performance and key metrics
CBD
Psychosis
C105
Cognition Disorders
golexanolone
Primary Biliary Cholangitis (PBC)
CT1812
Early Alzheimer's Disease
Dexmedetomidine
Alzheimer Disease
Dexmedetomidine and Midodrine
Alzheimer Disease
Active Treatment- CT1812
Alzheimer Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CBD | Phase 3 | Psychosis | - | - |
C105 | Phase 2 | Cognition Disorders | - | - |
golexanolone | Phase 2 | Primary Biliary Cholangitis (PBC) | - | - |
CT1812 | Phase 2 | Early Alzheimer's Disease | - | - |
Dexmedetomidine | Phase 2 | Alzheimer Disease | - | - |
Dexmedetomidine and Midodrine | Phase 2 | Alzheimer Disease | - | - |
Active Treatment- CT1812 | Phase 2 | Alzheimer Disease | - | - |
Frequently asked questions
What is in COGNITION THERAPEUTICS INC's drug pipeline?→
CatalystAlert tracks 7 drug candidates in COGNITION THERAPEUTICS INC's (CGTX) pipeline across Phase 3, Phase 2. Its lead program is CBD (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is COGNITION THERAPEUTICS INC's next FDA catalyst?→
COGNITION THERAPEUTICS INC's (CGTX) next tracked catalyst is a Phase 2 readout expected Q2 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CGTX biotech catalysts?→
Add CGTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow COGNITION THERAPEUTICS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.